206 related articles for article (PubMed ID: 33036973)
21. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
[TBL] [Abstract][Full Text] [Related]
22. Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis.
Talbot M
Semin Thromb Hemost; 1989 Jul; 15(3):293-301. PubMed ID: 2688102
[No Abstract] [Full Text] [Related]
23. Hirudin as anticoagulant in experimental hemodialysis.
Markwardt F; Nowak G; Bucha E
Haemostasis; 1991; 21 Suppl 1():149-55. PubMed ID: 1894190
[TBL] [Abstract][Full Text] [Related]
24. In vitro effect of hirudin on recalcification time.
Hirsh J; Spillert CR; Delle Donne EP; Lazaro EJ
J Natl Med Assoc; 1994 Aug; 86(8):627-8. PubMed ID: 7932843
[TBL] [Abstract][Full Text] [Related]
25. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.
Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G
Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047
[TBL] [Abstract][Full Text] [Related]
26. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
Zhang C; Yu A; Yuan B; Dong C; Yu H; Wang L; Wu C
Thromb Haemost; 2008 Feb; 99(2):324-30. PubMed ID: 18278181
[TBL] [Abstract][Full Text] [Related]
27. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
[TBL] [Abstract][Full Text] [Related]
28. Hirudin in haemodialysis.
Bucha E; Markwardt F; Nowak G
Thromb Res; 1990 Dec; 60(6):445-55. PubMed ID: 2082478
[TBL] [Abstract][Full Text] [Related]
29. Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factor Xa.
McKenzie CR; Abendschein DR; Eisenberg PR
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1285-91. PubMed ID: 8857926
[TBL] [Abstract][Full Text] [Related]
30. Effect of hirudin versus heparin on hemocompatibility of blood contacting biomaterials: an in vitro study.
Kopp R; Bernsberg R; Kashefi A; Mottaghy K; Rossaint R; Kuhlen R
Int J Artif Organs; 2005 Dec; 28(12):1272-7. PubMed ID: 16404704
[TBL] [Abstract][Full Text] [Related]
31. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
Bates SM; Weitz JI
Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
[TBL] [Abstract][Full Text] [Related]
32. Platelet functions in recombinant hirudin-anticoagulated blood.
Glusa E; Markwardt F
Haemostasis; 1990; 20(2):112-8. PubMed ID: 2363746
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting.
Bode C; Hanson SR; Schmedtje JF; Haber E; Mehwald P; Kelly AB; Harker LA; Runge MS
Circulation; 1997 Feb; 95(4):800-4. PubMed ID: 9054733
[TBL] [Abstract][Full Text] [Related]
34. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
35. Differential profiles of thrombin inhibitors (heparin, hirudin, bivalirudin, and dabigatran) in the thrombin generation assay and thromboelastography in vitro.
Xu Y; Wu W; Wang L; Chintala M; Plump AS; Ogletree ML; Chen Z
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):332-8. PubMed ID: 23348428
[TBL] [Abstract][Full Text] [Related]
36. Engineering of a staphylokinase-based fibrinolytic agent with antithrombotic activity and targeting capability toward thrombin-rich fibrin and plasma clots.
Lian Q; Szarka SJ; Ng KK; Wong SL
J Biol Chem; 2003 Jul; 278(29):26677-86. PubMed ID: 12736246
[TBL] [Abstract][Full Text] [Related]
37. [Hirudin and hirudin fragments].
Deschamps A; Samama M
Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):A49-53. PubMed ID: 1298182
[TBL] [Abstract][Full Text] [Related]
38. Development of hirudin as an antithrombotic agent.
Markwardt F
Semin Thromb Hemost; 1989 Jul; 15(3):269-82. PubMed ID: 2688099
[No Abstract] [Full Text] [Related]
39. Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro.
Gandossi E; Lunven C; Berry CN
Br J Pharmacol; 2000 Mar; 129(5):1021-7. PubMed ID: 10696104
[TBL] [Abstract][Full Text] [Related]
40. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
